C4 Therapeutics, Inc. (CCCC) — Shares Outstanding
| Fiscal Year | Shares Outstanding | Change YoY |
|---|---|---|
| 2025 | 96.91M | +37.2% |
| 2024 | 70.63M | +16.8% |
| 2023 | 60.47M | +23.5% |
| 2022 | 48.97M | +0.6% |
| 2021 | 48.69M | +13.1% |
| 2020 | 43.06M | +2918.3% |
| 2019 | 1.43M | — |
| Fiscal Year | Shares Outstanding | Change YoY |
|---|---|---|
| 2025 | 96.91M | +37.2% |
| 2024 | 70.63M | +16.8% |
| 2023 | 60.47M | +23.5% |
| 2022 | 48.97M | +0.6% |
| 2021 | 48.69M | +13.1% |
| 2020 | 43.06M | +2918.3% |
| 2019 | 1.43M | — |